ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Therapeutic landscape for diabetic macular edema: durable strategies with a focus on aflibercept 8 mg
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Diabetic Retinopathy Assessed by Ultra-wide#912671
- Aflibercept with and without laser therapy in diabetic macular edema: a systematic review and meta-analysis#353652
- Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)#851884
- Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema#234582
- A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)#892172
Record · ID 681888
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive